Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Quality Assurance of HCV-therapy With PegIntron® Plus Rebetol® in Drug-substituted Patients - SUPPORT Project Post-Marketing Surveillance Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00726557
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:05.992837+00:00
Published At
2010-05-17T00:00:00+00:00
Record Updated At
2015-10-09
Results Posted At
2010-05-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hepatitis C, Chronic", "Substance Abuse, Intravenous"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-10-09"
protocolSection.identificationModule.nctId
"NCT00726557"
protocolSection.identificationModule.officialTitle
"Quality Assurance of HCV-therapy With PegIntron\u00ae Plus Rebetol\u00ae in Drug-substituted Patients - SUPPORT Project Post-Marketing Surveillance Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2010-05-17"

Study condition terms

  • Hepatitis C, Chronic (protocolSection.conditionsModule.conditions)
  • Substance Abuse, Intravenous (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.